PTPN23
Basic information
Region (hg38): 3:47381011-47413435
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic; Ophthalmologic | 25558065; 27848944; 29090338; 29899372; 31395947 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (21 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPN23 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 405 | 11 | 421 | |||
missense | 556 | 15 | 11 | 582 | ||
nonsense | 12 | |||||
start loss | 1 | |||||
frameshift | 14 | 11 | 29 | |||
inframe indel | 27 | 28 | ||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 20 | 42 | 4 | 66 | ||
non coding | 140 | 10 | 154 | |||
Total | 21 | 9 | 610 | 561 | 35 |
Highest pathogenic variant AF is 0.0000329
Variants in PTPN23
This is a list of pathogenic ClinVar variants found in the PTPN23 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-47381098-T-C | Uncertain significance (Jun 14, 2022) | |||
3-47381105-C-T | Likely benign (Jan 10, 2024) | |||
3-47381144-G-A | Likely benign (Jun 15, 2021) | |||
3-47381148-G-T | Uncertain significance (Jan 17, 2024) | |||
3-47381160-T-C | Uncertain significance (Jun 13, 2022) | |||
3-47381172-G-C | Uncertain significance (Apr 11, 2022) | |||
3-47381173-TGAA-T | Uncertain significance (Sep 16, 2021) | |||
3-47381182-T-A | Likely pathogenic (Jul 07, 2023) | |||
3-47381189-G-A | Likely benign (Dec 13, 2023) | |||
3-47381189-G-C | Likely benign (Mar 18, 2022) | |||
3-47381190-C-G | Likely benign (Aug 10, 2023) | |||
3-47381192-T-G | Likely benign (Jun 09, 2023) | |||
3-47381194-C-G | Likely benign (Aug 31, 2022) | |||
3-47381195-C-T | Likely benign (Mar 15, 2021) | |||
3-47381196-A-G | Likely benign (Feb 10, 2023) | |||
3-47381197-T-C | Likely benign (Apr 19, 2022) | |||
3-47381198-C-A | Likely benign (Oct 27, 2022) | |||
3-47381199-T-TA | Likely benign (Jan 29, 2024) | |||
3-47381200-T-A | Likely benign (Jan 29, 2024) | |||
3-47396129-T-C | Likely benign (Jun 27, 2022) | |||
3-47396129-TTC-T | Likely benign (Aug 23, 2022) | |||
3-47396139-G-C | Likely benign (Dec 19, 2023) | |||
3-47396160-T-C | Likely benign (May 01, 2023) | |||
3-47396167-A-G | Uncertain significance (Aug 21, 2022) | |||
3-47396200-C-T | PTPN23-related disorder | Likely benign (Jan 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPN23 | protein_coding | protein_coding | ENST00000265562 | 25 | 32431 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0313 | 0.969 | 125663 | 0 | 85 | 125748 | 0.000338 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.33 | 872 | 990 | 0.881 | 0.0000619 | 10480 |
Missense in Polyphen | 115 | 150.34 | 0.76491 | 1565 | ||
Synonymous | -1.75 | 472 | 426 | 1.11 | 0.0000273 | 3513 |
Loss of Function | 5.88 | 18 | 71.7 | 0.251 | 0.00000382 | 773 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000669 | 0.000640 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.000996 | 0.000971 |
European (Non-Finnish) | 0.000266 | 0.000246 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.000401 | 0.000392 |
Other | 0.000692 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs) via its interaction with the ESCRT-I complex (endosomal sorting complex required for transport I), and possibly also other ESCRT complexes. May act as a negative regulator of Ras-mediated mitogenic activity. Plays a role in ciliogenesis. {ECO:0000269|PubMed:18434552, ECO:0000269|PubMed:20393563, ECO:0000269|PubMed:21757351}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.516
- rvis_EVS
- -1.33
- rvis_percentile_EVS
- 4.68
Haploinsufficiency Scores
- pHI
- 0.0975
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.593
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.745
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptpn23
- Phenotype
- vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- negative regulation of epithelial cell migration;protein transport;endocytic recycling;peptidyl-tyrosine dephosphorylation;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;early endosome to late endosome transport;cilium assembly;positive regulation of Wnt protein secretion;cellular response to cytokine stimulus;positive regulation of homophilic cell adhesion;positive regulation of adherens junction organization;positive regulation of early endosome to late endosome transport
- Cellular component
- nucleus;nucleoplasm;cytoplasm;endosome;early endosome;cytosol;nuclear body;ciliary basal body;extracellular exosome
- Molecular function
- protein tyrosine phosphatase activity;protein binding;protein kinase binding